vaccine

(redirected from dendritic cell vaccine)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to dendritic cell vaccine: sipuleucel-T
  • noun

Synonyms for vaccine

Synonyms for vaccine

immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies

References in periodicals archive ?
Dendritic cell vaccines provide another form of therapy for conditions that cannot be addressed with chemotherapy or radiation, such as metastatic renal cancer or malignant melanoma.
Palucka is working to develop a dendritic cell vaccine against triple-negative tumors based on long peptides.
In the first quarter of 2013, we anticipate the initiation of an investigator-sponsored Phase I trial of ICT-121, a dendritic cell vaccine targeting CD133, in patients with recurrent glioblastoma.
We are planning to initiate a 20-patient, investigator-sponsored Phase I trial of ICT-121, a dendritic cell vaccine targeting CD133, in patients with recurrent glioblastoma, also before the end of 2012.
These data demonstrate that our dendritic cell vaccine, ICT-107, which was designed to target both cancer cells and cancer stem cells, has the potential to significantly delay disease recurrence, and thus increase survival in GBM," said Manish Singh, Ph.
Steve's broad experience in immunology drug discovery and development, as well as his regulatory knowledge and worldwide reputation as an immunogenicity thought-leader will be valuable assets to ImmunoCellular both in advancing this new stem cell platform and potentially enhancing our dendritic cell vaccine platform.
Rosenthal will introduce the LEAPS dendritic cell vaccine approach as a potentially new personalized immunotherapy for chronic viral infections and tumors at the Cancer Vaccine Meeting in Cambridge, Mass.
The company's lead immunotherapy programs include a CTA targeted dendritic cell vaccine in Phase 1/2 development for multiple tumor types and an NIH supported CTA targeted oral cancer vaccine in preclinical development for ovarian and other cancers.
AST-VAC2 (antigen-presenting allogeneic dendritic cells) represents a second generation, allogeneic approach to dendritic cell vaccines.
In order to make dendritic cell vaccines some of the patient's dendritic cells are extracted and immune cell stimulants are used to reproduce large amounts of dendritic cells in the lab.
The company is focusing on development of its dendritic cell vaccines.
If the melanoma trial is successful, ML will be seeking partners interested in using the technology to develop dendritic cell vaccines for a range of life threatening diseases.
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Focus on current trends in cancer immunotherapies that include: anti-PD-1 drugs, Dendritic cell vaccines, T-cell therapies and cancer vaccines.